ASCO 2013 - Poster: Correlation between baseline variables and survival in the radium-223 dichloride phase III ALSYMPCA trial with attention to total ALP changes

CHICAGO, IL USA ( - Presented by O. Sartor,1 R. Amariglio,2 S. Wilhelm,2 J. Garcia-Vargas,2 C.G. O’Bryan-Tear,3 M. Shan,2 F. Fang,2 and C. Parker4 at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 31 - June 4, 2013 - McCormick Place - Chicago, IL USA

asco 2013 sartor poster thumb

1Tulane Cancer Center, New Orleans, LA, USA; 2Bayer HealthCare, Montville, NJ, USA; 3Algeta ASA, Oslo Norway; 4The Royal Marsden NHS Foundation Trust, Sutton, UK

Click HERE to listen to a podcast by A. Oliver Sartor, MD, one of the participants in this study


The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Building Bridges to Conquer Cancer." 

asco x

View Full ASCO 2013 Coverage